progenity
announces
addition
russell
index
san
diego
globe
newswire
progenity
nasdaq
prog
biotechnology
company
established
track
record
success
developing
commercializing
molecular
testing
products
today
announced
added
russell
index
effective
market
opens
friday
september
russell
index
measures
performance
segment
equity
market
russell
indexes
widely
used
investment
managers
institutional
investors
index
funds
benchmarks
active
investment
strategies
approximately
trillion
assets
benchmarked
russell
indexes
russell
indexes
part
ftse
russell
leading
global
index
provider
progenity
progenity
biotechnology
company
established
track
record
success
developing
commercializing
molecular
testing
products
well
innovating
field
precision
medicine
progenity
provides
vitro
molecular
tests
designed
improve
lives
providing
actionable
information
helps
guide
patients
physicians
making
medical
decisions
key
life
stages
company
applies
approach
combining
genomics
epigenomics
proteomics
metabolomics
molecular
testing
products
development
suite
investigational
ingestible
devices
designed
provide
precise
diagnostic
sampling
drug
delivery
solutions
progenity
vision
transform
healthcare
become
precise
personal
improving
diagnoses
disease
improving
patient
outcomes
localized
treatment
targeted
therapies
additional
information
progenity
please
visit
company
website
investor
contact
robert
uhl
managing
director
westwicke
icr
ir
media
contact
kate
cg
life
kblomlowery
